Found: 4
Select item for more details and to access through your institution.
A New Heteroleptic Zn(II) Complex with Schiff Bases Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 12, p. 1610, doi. 10.3390/pharmaceutics16121610
- By:
- Publication type:
- Article
Tailoring Potential Natural Compounds for the Treatment of Luminal Breast Cancer.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 10, p. 1466, doi. 10.3390/ph16101466
- By:
- Publication type:
- Article
A Novel Compound from the Phenylsulfonylpiperazine Class: Evaluation of In Vitro Activity on Luminal Breast Cancer Cells.
- Published in:
- Molecules, 2024, v. 29, n. 18, p. 4471, doi. 10.3390/molecules29184471
- By:
- Publication type:
- Article
Endothelial dysfunction due to the inhibition of the synthesis of nitric oxide: Proposal and characterization of an in vitro cellular model.
- Published in:
- Frontiers in Physiology, 2022, v. 13, p. 1, doi. 10.3389/fphys.2022.978378
- By:
- Publication type:
- Article